CONMED (CNMD) risk factors

Item 1A of every CONMED Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open CNMD in Gloom →

CONMED's chart, financials and news, free in your browser.Open CNMD in Gloom →

FY2025 10-K risk factors
38 risks7 new3 dropped10 reworded
CONMED added risks concerning AI adoption, divestitures, and healthcare compliance penalties. Capital products yielded 14% of 2025 revenues, while international sales contributed 44%. The company suspended its quarterly dividend in October 2025 and terminated its W.L. Gore & Associates distribution agreement in December 2025.
Filed Feb 17, 2026
FY2024 10-K risk factors
34 risks
This company has no prior year risk disclosures on file.
Filed Feb 18, 2025